Rare diseases in ICD11: making rare diseases visible in health information systems through appropriate coding

Orphanet Journal of Rare Diseases

Ana Rath¹  Bertrand Bellet¹  Ségolène Aymé¹ 

[1] INSERM, US14 – Orphanet, Paris, France, Rare Diseases Platform, 96 rue Didot, Paris, France

关键词: Coding system;    Classification;    Rare diseases;   

Others  :  1150881
DOI  :  10.1186/s13023-015-0251-8

 received in 2015-01-20, accepted in 2015-03-09,  发布年份 2015

【 摘 要 】

Background

Because of their individual rarity, genetic diseases and other types of rare diseases are under-represented in healthcare coding systems; this contributes to a lack of ascertainment and recognition of their importance for healthcare planning and resource allocation, and prevents clinical research from being performed.

Methods

Orphanet was given the task to develop an inventory of rare diseases and a classification system which could serve as a template to update International terminologies. When the World Health Organization (WHO) launched the revision process of the International Classification of Diseases (ICD), a Topic Advisory Group for rare diseases was established, managed by Orphanet and funded by the European Commission.

Results

So far 5,400 rare diseases listed in the Orphanet database have an endorsed representation in the foundation layer of ICD-11, and are thus provided with a unique identifier in the Beta version of ICD-11, which is 10 times more than in ICD10. A rare disease linearization is also planned. The current beta version is open for public consultation and comments, and to be used for field testing. The adoption by the World Health Assembly is planned for 2017.

Conclusions

The overall revision process was carried out with very limited means considering its scope, ambition and strategic significance, and experienced significant hurdles and setbacks. The lack of funding impacted the level of professionalism that could be attained. The contrast between the initially declared goals and the currently foreseen final product is disappointing. In the context of uncertainty around the outcome of the field testing and the potential willingness of countries to adopt this new version, the European Commission Expert Group on Rare Diseases adopted in November 2014 a recommendation for health care coding systems to consider using ORPHA codes in addition to ICD10 codes for rare diseases having no specific ICD10 codes. The Orphanet terminology, classifications and mappings with other terminologies are freely available at www.orphadata.org webcite.

【 授权许可】

   
2015 Aymé et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Rodwell C, Aymé S, eds. 2014 Report on the State of the Art of Rare Disease Activities in Europe, July 2014. [http://www.eucerd.eu/upload/file/Reports/2014ReportStateofArtRDActivities.pdf]. Accessed 19 January 2015.
• [2]Regulation (EC) N°141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products, 16 December 1999. [http://lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2000:018:0001:0005:en:PDF] Accessed 19 January 2015.
• [3]Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2014 Nov 26. [Epub ahead of print].
• [4]Rath A, Olry A, Dhombres F, Brandt MM, Urbero B, Aymé S: Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users. Hum Mutat 2012, 33(5):803-8.
• [5]Orphanet: Orphanet 2013 Activity Report. [http://www.orpha.net/orphacom/cahiers/docs/GB/ActivityReport2013.pdf] Accessed 19 January 2015.
• [6]Miličić Brandt M, Rath A, Devereau A, Aymé S. Mapping Orphanet terminology to UMLS. In “Artificial Intelligence in Medicine: proceedings of the 13th conference on artificial intelligence in Medicine”, AIME 2011, ISBN 978-3-642-22217-7, pp. 194-203, 2011.
• [7]World Health Organization. Terms of reference of the Topic Advisory Groups. [http://www.who.int/classifications/TOR_TAGs_WGs.pdf?ua=1] Accessed 19 January 2015.
• [8]World Health Organization. Revision Steering Group webpage. [http://www.who.int/classifications/icd/RSG/en/] Accessed 19 January 2015.
• [9]Tu SW, Bodenreider O, Çelik C, Chute CG, Heard S, Jakob R, et al. A Content Model for the ICD-11 Revision. [https://wiki.nci.nih.gov/download/attachments/25136344/BMIR-2010-1405.pdf] Accessed 19 January 2015.
• [10]Tudorache T, Falconer S, Nyulas C, Storey MA, Ustün TB, Musen MA: Supporting the collaborative authoring of ICD-11 with WebProtégé. AMIA Annu Symp Proc 2010, 2010:802-6.
• [11]Demoly P, Tanno LK, Akdis CA, Lau S, Calderon MA, Santos AF, et al.: Global classification and coding of hypersensitivity diseases - An EAACI - WAO survey, strategic paper and review. Allergy 2014, 69(5):559-70. PMID 24650345
• [12]Chute CG. Distributed biomedical terminology development: from experiments to open process. Yearb Med Inform. 2010:58–63. Review. PubMed PMID: 20938572.
• [13]World Health Organization, ICD Revision Information Notes. [http://www.who.int/classifications/icd/revision/informationnotes/en/] Accessed 19 January 2015.
• [14]Huang J, Manos A, Shah A, Wu JP, Robinson Nicol MM. Standardizing short definitions for the new ICD. Poster presented at the WHO – family of international classification network annual meeting 2014, 11–17 October 2014, Barcelona, Spain. Online presentation: [http://prezi.com/9cnw6b628vln/standardizing-short-definitions-for-the-new-icd/] Accessed 19 January 2015
• [15]Rajakulendran S, Dua T, Harper M, Shakir R: The classification of neurological disorders in the 11th revision of the international classification of diseases (ICD-11). J Neurol Neurosurg Psychiatry 2014, 85(9):952-3.
• [16]Hennekam RC, Biesecker LG: Next-generation sequencing demands next-generation phenotyping. Hum Mutat 2012, 33(5):884-6.
• [17]European Commission Expert Group on Rare Diseases: “Recommendation on Ways to Improve Codification for Rare Diseases in Health Information Systems”, November 2014. [http://ec.europa.eu/health/rare_diseases/docs/recommendation_coding_cegrd_en.pdf] Accessed 19 January 2015.
• [18]National plans or strategies for rare diseases. [http://ec.europa.eu/health/rare_diseases/national_plans/detailed/index_en.htm] Accessed 19 January 2015.
• [19]Mazzucato M, Visonà Dalla Pozza L, Manea S, Minichiello C, Facchin P: A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto region’s rare diseases registry. Orphanet J Rare Dis 2014, 9:37. BioMed Central Full Text